Moderna Files for FDA Approval of Its COVID Vaccine in Teens
On Thursday, Moderna (NASDAQ: MRNA) announced it has filed for Emergency Use Authorization for its COVID-19 vaccine in adolescents from 12 to 18. If the agency gives Moderna a green light, parents will have another vaccine option beyond Pfizer (NYSE: PFE) and BioNTech's (NASDAQ: BNTX) vaccine, which was approved for ages 12 to 18 in May. Drugmakers including Moderna have developed vaccines to help prevent severe disease, and over the past few months, governments have made significant progress in vaccinating adult populations.
